Gene mutations that preferentially affect the CNS have been implicated in a number of neurological disorders. This leads to the possibility that a disease-causing mutation present only in CNS tissues could be missed if it were tested in a blood DNA sample only. The commonest mutation in amyotrophic lateral sclerosis (ALS) is an expansion of the hexanucleotide repeats of C9orf72. To find out if CNS-specific mutations of this gene could cause some cases of ALS we looked for differences in the size of C9orf72 repeats between DNA from the CNS and from white blood cells (WBCs) of 38 sporadic ALS patients, using a repeat-primed PCR screening test. We also looked for differences in C9orf72 repeats in WBC DNA from 6 ALS-discordant and 1 ALS-concordant monozygotic twins. Abnormally expanded C9orf72 repeats were found in 13% of the ALS CNS samples, as well as in their paired WBC DNA. The 87% of ALS CNS samples with normal-sized C9orf72 repeats had the same number of repeats in paired WBC samples. All ALS-discordant twins had the same normal numbers of WBC C9orf72 repeats. Although previous work suggests some tissue mosaicism in C9orf72 repeat size is probably present, this study indicates that this is not likely to be of sufficient magnitude to result in a normal C9orf72 repeat length in blood but an abnormally expanded repeat length in the CNS. This suggests that a blood DNA test alone will usually be sufficient to make a diagnosis of C9orf72 repeat-related ALS.
References
[1]
Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, et al. (2013) Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12: 310–322.
[2]
Chio A, Calvo A, Mazzini L, Cantello R, Mora G, et al. (2012) Extensive genetics of ALS: A population-based study in Italy. Neurology 79: 1983–1989.
[3]
Mitchell JD (2000) Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 235–250.
[4]
Youssoufian H, Pyeritz RE (2002) Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet 3: 748–758.
[5]
Soriano P, Jaenisch R (1986) Retroviruses as probes for mammalian development: allocation of cells to the somatic and germ cell lineages. Cell 46: 19–29.
[6]
Beck JA, Poulter M, Campbell TA, Uphill JB, Adamson G, et al. (2004) Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease. Hum Mol Genet 13: 1219–1224.
[7]
Pamphlett R (2004) Somatic mutation: a cause of sporadic neurodegenerative diseases? Med Hypotheses 62: 679–682.
[8]
Tan Q, Ohm Kyvik K, Kruse TA, Christensen K (2010) Dissecting complex phenotypes using the genomics of twins. Funct Integr Genomics 10: 321–327.
[9]
Vadlamudi L, Dibbens LM, Lawrence KM, Iona X, McMahon JM, et al. (2010) Timing of de novo mutagenesis–a twin study of sodium-channel mutations. N Engl J Med 363: 1335–1340.
[10]
Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257–268.
[11]
Dejesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 72: 245–256.
[12]
Hashida H, Goto J, Kurisaki H, Mizusawa H, Kanazawa I (1997) Brain regional differences in the expansion of a CAG repeat in the spinocerebellar ataxias: dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and spinocerebellar ataxia type 1. Ann Neurol 41: 505–511.
[13]
Majounie E, Renton AE, Mok K, Dopper EG, Waite A, et al. (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11: 323–330.
[14]
Buchman VL, Cooper-Knock J, Connor-Robson N, Higginbottom A, Kirby J, et al. (2013) Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation. Mol Neurodegener 8: 12.
[15]
Al-Chalabi A, Fang F, Hanby MF, Leigh PN, Shaw CE, et al. (2010) An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 81: 1324–1326.
[16]
Pamphlett R, Morahan JM (2011) Copy number imbalances in blood and hair in monozygotic twins discordant for amyotrophic lateral sclerosis. J Clin Neurosci 18: 1231–1234.
[17]
Vance C, Al-Chalabi A, Ruddy D, Smith BN, Hu X, et al. (2006) Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2–21.3. Brain 129: 868–876.
[18]
Boeve BF, Boylan KB, Graff-Radford NR, Dejesus-Hernandez M, Knopman DS, et al. (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135: 765–783.
[19]
Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, et al. (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11: 54–65.
[20]
Chio A, Borghero G, Restagno G, Mora G, Drepper C, et al. (2012) Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 135: 784–793.
[21]
Pamphlett R, Cheong PL, Trent RJ, Yu B (2012) Transmission of C9orf72 hexanucleotide repeat expansions in sporadic amyotrophic lateral sclerosis: an Australian trio study. Neuroreport 23: 556–559.
[22]
Shaw PJ, Tomkins J, Slade JY, Usher P, Curtis A, et al. (1997) CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND). Neuroreport 8: 3923–3927.
[23]
Saunderson RB, Yu B, Trent RJ, Pamphlett R (2008) A comparison of the lengths of androgen receptor triplet repeats in brain and blood in motor neuron diseases. J Neurol Sci 267: 125–128.
[24]
Luquin N, Yu B, Trent RJ, Morahan JM, Pamphlett R (2008) An analysis of the entire SOD1 gene in sporadic ALS. Neuromuscul Disord 18: 545–552.
[25]
Luquin N, Yu B, Saunderson RB, Trent RJ, Pamphlett R (2009) Genetic variants in the promoter of TARDBP in sporadic amyotrophic lateral sclerosis. Neuromuscul Disord 19: 696–700.
[26]
Luquin N, Yu B, Trent RJ, Pamphlett R (2010) DHPLC can be used to detect low-level mutations in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11: 76–82.
[27]
Pamphlett R, Morahan JM, Luquin N, Yu B (2011) Looking for differences in copy number between blood and brain in sporadic amyotrophic lateral sclerosis. Muscle Nerve 44: 492–498.
[28]
Morahan JM, Yu B, Trent RJ, Pamphlett R (2009) A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10: 418–429.
[29]
Fogh I, Rijsdijk F, Andersen PM, Sham PC, Knight J, et al. (2007) Age at onset in sod1-mediated amyotrophic lateral sclerosis shows familiality. Neurogenetics 8: 235–236.
[30]
Belzil VV, Rouleau GA (2012) Familial ALS: less common than we think? J Neurol Neurosurg Psychiatry 83: 1133.
[31]
Byrne S, Walsh C, Lynch C, Bede P, Elamin M, et al. (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82: 623–627.
[32]
Conte A, Lattante S, Luigetti M, Del Grande A, Romano A, et al. (2012) Classification of familial amyotrophic lateral sclerosis by family history: effects on frequency of genes mutation. J Neurol Neurosurg Psychiatry 83: 1201–1203.
